|
Real-time Estimate
Tradegate
23:27:47 12/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 222.20 EUR | -1.46% |
|
-0.49% | -5.19% |
| 08-11 | Berenberg Adjusts UCB Forecasts After H1 Beat; Buy Reaffirmed | MT |
| 08-11 | UCB barely moves despite positive calls from ING and Berenberg |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UCB | Biopharmaceuticals | -1.20% | -0.49% | -5.19% | +19.34% | +129.93% | 49.77B |
-
|
-
|
-
|
- Stock Market
- Stocks
- UCB Stock
- UNC Stock
- Charts UCB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
